Reid Hoffman Thinks Doctors Should Ask AI for a Second Opinion
Reid Hoffman, LinkedIn cofounder and entrepreneur, advocates for using advanced AI models as a second opinion in medical decision-making, arguing that not doing so may border on malpractice. His AI drug discovery startup, Manas AI, aims to accelerate the development of cancer treatments and expand into rare diseases. Hoffman believes generative AI can enhance diagnostics, support overburdened health systems like the NHS, and assist regulators, though human oversight remains essential.
Opening excerpt (first ~120 words) tap to expand
David CoxScienceApr 30, 2026 5:00 AMReid Hoffman Thinks Doctors Should Ask AI for a Second OpinionThe LinkedIn cofounder now has an AI drug discovery startup—and thinks not asking chatbots for medical advice is “bordering on committing malpractice.”Photograph: FERNANDO BRAZCommentLoaderSave StorySave this storyCommentLoaderSave StorySave this storyFollowing a three-decade career at the helm of some of Silicon Valley’s most powerful companies—cofounding LinkedIn and sitting on the boards of PayPal and OpenAI—Reid Hoffman recently turned his attention to health care.Hoffman’s startup, Manas AI, is building an AI engine that aims to fast-track the traditionally slow process of drug discovery for various cancers.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at WIRED.
Discussion
0 commentsMore from WIRED
.jpg)